How to buy Akers Biosciences stock | 1.94

Akers Biosciences, Inc is a medical instruments & supplies business based in the US. Akers Biosciences shares (AKER) are listed on the NASDAQ and all prices are listed in US Dollars. Akers Biosciences employs 12 staff and has a trailing 12-month revenue of around USD$862,026.

How to buy shares in Akers Biosciences

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Akers Biosciences. Find the stock by name or ticker symbol: AKER. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Akers Biosciences reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of USD$1.94, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Akers Biosciences, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Akers Biosciences. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted Akers Biosciences's share price?

Since the stock market crash in March caused by coronavirus, Akers Biosciences's share price has had significant negative movement.

Its last market close was USD$1.94, which is 43.36% down on its pre-crash value of USD$3.425 and 25.16% up on the lowest point reached during the March crash when the shares fell as low as USD$1.55.

If you had bought USD$1,000 worth of Akers Biosciences shares at the start of February 2020, those shares would have been worth USD$647.06 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$633.99.

Akers Biosciences share price

Use our graph to track the performance of AKER stocks over time.

Akers Biosciences shares at a glance

• Key figures

Information last updated 2020-10-19.

Latest market close	USD$1.94
52-week range	USD$0.2601 - USD$8.85
50-day moving average	USD$2.3335
200-day moving average	USD$3.6658
Wall St. target price	USD$4
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-0.715

Buy Akers Biosciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy Akers Biosciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Akers Biosciences, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Akers Biosciences price performance over time

Historical closes compared with the close of $1.94 from 2020-11-16

1 week (2020-11-18)	2.65%
1 month (2020-10-23)	-12.22%
3 months (2020-08-25)	-52.45%
6 months (2020-05-22)	-39.56%

1 year (2019-11-25)	-72.68%
2 years (2018-11-23)	13.45%
3 years (2017-11-24)	240.35%
5 years (2015-11-25)	-0.51%

Akers Biosciences financials

Revenue TTM	USD$862,026
Gross profit TTM	USD$478,747
Return on assets TTM	-43.23%
Return on equity TTM	-92.11%
Profit margin	0%
Book value	$2.54
Market capitalisation	USD$19.8 million

TTM: trailing 12 months

Shorting Akers Biosciences shares

There are currently 478,174 Akers Biosciences shares held short by investors – that's known as Akers Biosciences's "short interest". This figure is 18.7% up from 402,839 last month.

There are a few different ways that this level of interest in shorting Akers Biosciences shares can be evaluated.

Akers Biosciences's "short interest ratio" (SIR)

Akers Biosciences's "short interest ratio" (SIR) is the quantity of Akers Biosciences shares currently shorted divided by the average quantity of Akers Biosciences shares traded daily (recently around 956348). Akers Biosciences's SIR currently stands at 0.5. In other words for every 100,000 Akers Biosciences shares traded daily on the market, roughly 500 shares are currently held short.

However Akers Biosciences's short interest can also be evaluated against the total number of Akers Biosciences shares, or, against the total number of tradable Akers Biosciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Akers Biosciences's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Akers Biosciences shares in existence, roughly 50 shares are currently held short) or 0.0548% of the tradable shares (for every 100,000 tradable Akers Biosciences shares, roughly 55 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Akers Biosciences.

Find out more about how you can short Akers Biosciences stock.

Akers Biosciences share dividends

We're not expecting Akers Biosciences to pay a dividend over the next 12 months.

Have Akers Biosciences's shares ever split?

Akers Biosciences's shares were split on a 1:24 basis on 25 November 2019. So if you had owned 24 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Akers Biosciences shares – just the quantity. However, indirectly, the new 2300% higher share price could have impacted the market appetite for Akers Biosciences shares which in turn could have impacted Akers Biosciences's share price.

Akers Biosciences share price volatility

Over the last 12 months, Akers Biosciences's shares have ranged in value from as little as $0.2601 up to $8.85. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Akers Biosciences's is 0.2344. This would suggest that Akers Biosciences's shares are less volatile than average (for this exchange).

Akers Biosciences overview

Akers Biosciences, Inc., together with its subsidiaries, develops, produces, and sells rapid screening and testing products designed to deliver medical devices to healthcare providers and consumers in the United States, the People's Republic of China, and internationally. Its products include BreathScan, a disposable breath alcohol detector; PIFA Heparin/PF4 and PIFA PLUSS PF4 rapid tests for Heparin/PF4 antibodies to detect an allergy to the used blood thinner, Heparin; seraSTAT, a rapid blood cell separator; Tri-Cholesterol ?Check', a rapid test for total and high density lipoprotein cholesterol and estimates low density lipo protein; and BreathScan OxiCHek that detects aldehydes or oxidative stress in exhaled human breath. The company was founded in 1989 and is headquartered in Thorofare, New Jersey.

Frequently asked questions

• What percentage of Akers Biosciences is owned by insiders or institutions?

  Currently 0.83% of Akers Biosciences shares are held by insiders and 9.298% by institutions.

• How many people work for Akers Biosciences?

  Latest data suggests 12 work at Akers Biosciences.

• When does the fiscal year end for Akers Biosciences?

  Akers Biosciences's fiscal year ends in December.

• Where is Akers Biosciences based?

  Akers Biosciences's address is: 201 Grove Road, Thorofare, NJ, United States, 08086

• What is Akers Biosciences's ISIN number?

  Akers Biosciences's international securities identification number is: US00973E1029

• What is Akers Biosciences's CUSIP number?

  Akers Biosciences's Committee on Uniform Securities Identification Procedures number is: 00973E102